The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind, randomized cross-over pilot phase II trial.
G. R. Nuñez
No relevant relationships to disclose
A. Del Giglio
No relevant relationships to disclose
H. Pinczowski
No relevant relationships to disclose
R. M. Zanellato
No relevant relationships to disclose
L. C. Tateyama
No relevant relationships to disclose
F. Schindler
No relevant relationships to disclose
F. A. Fonseca
No relevant relationships to disclose